Foundation Medicine

Foundation Medicine
Partner Level
Company Headquarters
150 Second Street Cambridge, MA 02141
Visit Site

Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient’s unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine’s molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer. For more information, visit

Our Proven Portfolio. That’s Our Foundation.
FDA-approved tissue AND blood-based testing is available for all solid tumors with FoundationOne®CDx and FoundationOne®Liquid CDx. In addition, FoundationOne®Heme is a laboratory developed test for hematologic malignancies, sarcomas, or solid tumors where fusion detection is desired. There is also the option to add on immunohistochemistry (IHC) testing.

For more information about our tests, please visit

Client Services

Twitter @FoundationATCG
LinkedIn Foundation Medicine
YouTube Foundation Medicine

© 2021 FLASCO | Premium Website Design by The HDG